CompletedPhase 1NCT00386906

Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma

Studying Conjunctival malignant melanoma

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: M.D. Anderson Cancer Center
Principal Investigator: Bita Esmaeli, MD
M.D. Anderson Cancer Center
Intervention: Sentinel Lymph Node Mapping and Biopsy(procedure)
Enrollment: 38 enrolled
Eligibility: 18 years · All sexes
Timeline: 2000 – 2023

Study locations (1)

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00386906 on ClinicalTrials.gov

Other trials for Conjunctival malignant melanoma

Additional recruiting or active studies for the same condition.

RECRUITINGNCT05797415
Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers
Fondazione Policlinico Universitario Agostino Gemelli IRCCS

See all trials for Conjunctival malignant melanoma →

← Back to all trials